Juan Pablo Robles
Founder & Associate Researcher ViAn Therapeutics & UNAM
Juan Pablo Robles, M.Sc., Ph.D., is an Associate Researcher at the National University of Mexico (UNAM) and Founder of VIAN Therapeutics. With more than a decade of research in angiogenesis and vascular biology, his work led to the discovery and development of a novel peptide-based mechanism for angiogenesis inhibition, now central to VIAN’s therapeutic pipeline. His research focuses on translating vascular biology into new treatments for ocular disease, including non-invasive approaches to retinal drug delivery, with the goal of expanding access to effective therapies worldwide.
Seminars
Thursday 21st January 2027
Advancing Topical Retinal Drug Delivery to Reduce Treatment Burden & Expand Global Access
2:30 pm
- Understand how to overcome the biological barriers that have historically limited topical drug delivery to the retina and unlock new opportunities for non-invasive treatment
- Explore formulation strategies that improve retinal penetration and therapeutic activity while maintaining ocular safety and tolerability, and enable convenient dosing to enhance adherence and long-term treatment success
- Learn how next-generation topical therapies could reduce reliance on intravitreal injections while expanding access to retinal disease treatment for underserved patient populations worldwide
